argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis

Sunday, September 24, 2017 1 min read

Key Takeaway: argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis

Full Press Release Details

argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis.